Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-24 Purchase |
2021-11-29 08:00 am |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
3,780 | $79.33 | $299,867 | 65,678 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-07 Exercise |
2025-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
5,500 | $0 | 101,275 (Direct) |
View |
| 2025-03-10 Tax Withholding |
2025-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
3,463 | $100.13 | 101,275 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
24,920 | $0 | 101,275 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
17,500 | $0 | 74,318 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
8,504 | $103.7 | 74,318 (Direct) |
View |
| 2025-03-04 Tax Withholding |
2025-03-06 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
1,704 | $101.34 | 65,322 (Direct) |
View |
| 2025-03-03 Tax Withholding |
2025-03-04 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
715 | $103.77 | 67,026 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
3,500 | $0 | 17,500 (Direct) |
View |
| 2024-11-18 Tax Withholding |
2024-11-20 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
4,558 | $102.89 | 67,630 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
6,250 | $0 | 83,891 (Direct) |
View |
| 2024-06-24 Tax Withholding |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
2,182 | $164.64 | 83,891 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
11,750 | $0 | 83,891 (Direct) |
View |
| 2024-03-07 Tax Withholding |
2024-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
512 | $120.49 | 68,073 (Direct) |
View |
| 2024-03-08 Tax Withholding |
2024-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
909 | $123.14 | 68,073 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-06 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
1,728 | $125.32 | 69,494 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
778 | $126.19 | 83,722 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:00 pm |
2025-03-01 2034-03-01 |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
18,500 | $0 | 83,722 (Direct) |
View |
| 2023-11-17 Tax Withholding |
2023-11-20 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
4,508 | $82.98 | 65,751 (Direct) |
View |
| 2023-03-08 Tax Withholding |
2023-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
912 | $153.19 | 70,170 (Direct) |
View |
| 2023-03-06 Tax Withholding |
2023-03-08 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
1,134 | $157.21 | 98,082 (Direct) |
View |
| 2023-03-06 Option Award |
2023-03-08 8:00 pm |
2024-03-06 2033-03-06 |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
31,500 | $0 | 98,082 (Direct) |
View |
| 2023-03-01 Tax Withholding |
2023-03-03 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
522 | $147.57 | 67,716 (Direct) |
View |
| 2022-11-17 Tax Withholding |
2022-11-21 8:02 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
4,211 | $108.52 | 67,998 (Direct) |
View |
| 2022-03-04 Tax Withholding |
2022-03-08 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
1,216 | $79.2 | 120,111 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-08 8:00 pm |
2023-03-07 2032-03-07 |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
56,000 | $0 | 120,111 (Direct) |
View |
| 2022-03-01 Tax Withholding |
2022-03-01 8:03 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
572 | $75.05 | 65,327 (Direct) |
View |
| 2021-11-16 Option Award |
2021-11-17 8:03 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer |
40,000 | $0 | 61,898 (Direct) |
View |
| 2021-02-28 Tax Withholding(A) |
2021-03-10 8:01 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer |
565 | $86.97 | 21,780 (Direct) |
View |
| 2021-03-03 Option Award(A) |
2021-03-10 8:01 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer |
15,000 | $0 | 21,780 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:05 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer |
75,000 | $0 | 82,169 (Direct) |
View |
| 2020-12-14 Option Award |
2020-12-14 8:05 pm |
N/A 2030-12-14 |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer |
25,000 | $0 | 25,000 (Direct) |
View |
Ownership |
2020-12-14 8:01 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer |
0 | $0 | 138,544 (Direct) |
View |